Calidi Biotherapeutics (CLDI) Accumulated Expenses (2021 - 2026)
Calidi Biotherapeutics' Accumulated Expenses was $1.13 million in Q2 2026, down 41.5% from $1.93 million a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Calidi Biotherapeutics came in at $1.81 million, down 22.8% from FY2024.
- Accumulated Expenses shows a four-year compound annual growth rate of 51.0% (FY2021 to FY2025).
- In earlier years, Accumulated Expenses was $2.34 million in FY2024 (-57.0%), $5.43 million in FY2023 (+68.7%), $3.22 million in FY2022 (+827.5%) and $347,146 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Accumulated Expenses since Q3 2023.
- The best year-over-year quarter for Accumulated Expenses over five years was Q4 2022 (growth of 827.5%); the worst was Q3 2023 (a decline of 97.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Calidi Biotherapeutics | 1.50 Mn | -23.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 3.06 Mn |
| Jun 30, 2024 | 3.24 Mn |
| Mar 31, 2024 | 4.57 Mn |
| Dec 31, 2023 | 5.43 Mn |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 5.79 Mn |
| Mar 31, 2023 | 4.80 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 776,565.00 |
| Jun 30, 2022 | 345,851.00 |
| Mar 31, 2022 | 345,315.00 |
| Dec 31, 2021 | 347,146.00 |
API Access
Calidi Biotherapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();